News blog


  • BY: Andrew Hore |
  • POSTED: 24/12/2019 |

IXICO has extended two existing contracts and they will contribute an additional £2.4m in revenues. 

The neuroscience-focused data analytics company has secured a £1.8m extension to a phase III study in Huntingdon’s Disease and a £600,000 extension for a study in progressive supranuclear palsy.

The contracted order book was £15.9m at the end of September 2019. Other contracts have been added since then.

In the year to September, IXICO increased its revenues from £5.4m to £7.6m and it moved into profit for the first time. Pre-tax profit was £366,000.

There was £7.3m in the bank at the end of September 2019. 

© 2021 Aim Micro. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Browse by issue
All issues
Popular tags
All tags

betbrokers, financial, gold, health, leisure, media, mobile, resources, services, technology

AIM Micro feeds

Keep up to date with articles published at Subscribe to AIM Micro RSS Feeds